{"id":"W2967034948","doi":"10.1200/jco.2007.25.18_suppl.3594","title":"A phase I dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly and twice weekly erlotinib in advanced stage solid malignancies","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Rash; Pharmacokinetics; Erlotinib; Pharmacodynamics; Toxicity; Internal medicine; Adverse effect; Gastroenterology; Surgery; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001223167,0.001104606,0.001686492,0.0006100746,0.0004255853,0.0006713044,0.0008418262,0.0008674233,0.001982225],"category_scores_gemma":[0.0008779985,0.0005649757,0.0009992656,0.0005706765,0.0007876614,0.0007060997,0.0003290542,0.003637799,0.0004779532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007935268,"about_ca_system_score_gemma":0.001136741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005753096,"about_ca_topic_score_gemma":0.0009522076,"domain_scores_codex":[0.9995022,0.0002059475,0.00003146537,0.00009075244,0.0000684109,0.0001012747],"domain_scores_gemma":[0.9992877,0.0001208096,0.0001484816,0.00009691821,0.00004846772,0.0002977137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4332416,0.2328754,0.008018701,0.0006464511,0.001161663,0.0003155424,0.0006850534,0.006568846,0.1763695,0.0003574735,0.002948458,0.1368113],"study_design_scores_gemma":[0.2609715,0.705928,0.01618874,0.00001657216,0.0003074158,0.0003264501,0.00005217442,0.00237342,0.01152951,0.0001791415,0.002085094,0.00004183362],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997196,0.00039881,0.0004337363,0.0001225636,0.00003810683,0.0009866427,0.0002495733,0.00005553788,0.0005189844],"genre_scores_gemma":[0.9937637,0.0004623219,0.001914183,0.0002919071,0.0000617984,0.00143,0.0008572714,0.0000202081,0.001198492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001982225,"threshold_uncertainty_score":0.006631136,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07361737481403348,"score_gpt":0.5449734878466853,"score_spread":0.4713561130326518,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}